Funded Tech Companies
Ventus Therapeutics
Researching who provided funding to Ventus Therapeutics? GV, Alexandria Venture Investments and BVF Partners joined the equity holders in this innovative biopharmaceutical company.
Company Overview
Company Name
Ventus Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
100 Beaver St. 202
Waltham, MA 02453
USA
Waltham, MA 02453
USA
Phone
Website
Email Address
Company Background Information
Overview
At Ventus, we are focused on discovering and developing novel therapeutics that target the innate immune system with the goal of addressing autoimmune diseases, inflammatory diseases, and cancer. Guided by a patient-centric ethos, our aim is to rapidly advance multiple drug candidates. Our emerging pipeline focuses on the inflammasome and nucleic acid sensing pathways.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
2/18/2022
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chairman
Hao Wu
Chief Executive Officer
Marcelo Bigal
Chief Financial Officer
Zack McNealy
Founder
Richard Flavell
Founder
Judy Lieberman
Founder
Thomas Tuschl
Vice President
Michael Turner
VP - Bus. Development
Daniel Koerwer
VP - R & D
Michael Crackower
Company Investors
- GV
- Alexandria Venture Investments
- BVF Partners
- SoftBank Vision Fund (John Cassidy)
- Versant Ventures (Jerel Davis)
- RA Capital (Josh Resnick)
- Andreessen Horowitz
- Casdin Capital
- Cormorant Asset Management
- Fonds de solidarite FTQ
- Qatar Investment Authority
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs